TrialStem cell research & therapy2022

Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial.

Carmen Lúcia Kuniyoshi Rebelatto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.